Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
See Attems and Jellinger (doi:10.1093/brain/awx360) for a scientific commentary on this article.Cognitive changes occurring throughout the pathogenesis of neurodegenerative diseases are directly linked to synaptic loss. We used in-depth proteomics to compare 32 post-mortem human brains in the prefrontal cortex of prospectively followed patients with Alzheimer's disease, Parkinson's disease with dementia, dementia with Lewy bodies and older adults without dementia. In total, we identified 10 325 proteins, 851 of which were synaptic proteins. Levels of 25 synaptic proteins were significantly altered in the various dementia groups. Significant loss of SNAP47, GAP43, SYBU (syntabulin), LRFN2, SV2C, SYT2 (synaptotagmin 2), GRIA3 and GRIA4 were further validated on a larger cohort comprised of 92 brain samples using ELISA or western blot. Cognitive impairment before death and rate of cognitive decline significantly correlated with loss of SNAP47, SYBU, LRFN2, SV2C and GRIA3 proteins. Besides differentiating Parkinson's disease dementia, dementia with Lewy bodies, and Alzheimer's disease from controls with high sensitivity and specificity, synaptic proteins also reliably discriminated Parkinson's disease dementia from Alzheimer's disease patients. Our results suggest that these particular synaptic proteins have an important predictive and discriminative molecular fingerprint in neurodegenerative diseases and could be a potential target for early disease intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In both conditions, these altered functions largely originate from synaptic dysfunction relating to altered synaptic proteomes31,32.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies of postmortem human brains have found the significant association between cognitive decline and the loss of synaptic proteins in PFC, such as SNAP25, SNAP47, SV2C, SYT2 and GRIA3 253,254”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [253]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Synapses are the hub of neuron communications, and their degeneration is widely observed across multiple neurodegenerative diseases and increasingly recognized as a central cause of dementia 2,4,5,8,16 .”
From NAD+ hydrolase Sarm1 is a key driver of synapse degeneration and memory loss in Alzheimer’s disease (2025) · cites this paper as [16]
Experimental — accuracy not yet measuredIn the citing paper
“suggesting that these PFC synaptic markers are predictive molecular fingerprint for neurodegenerative diseases”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [253]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 1×
“Cognitive data were available for most patients and consisted of the last Mini-Mental State Examination (MMSE) scores, assessed in most cases within 1–2 years before death (Folstein et al., 1975) and MMSE decline calculated as average decline over a period of clinical observation of 8–10 years.”
MethodSystematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
Universal sample preparation method for proteome analysis
Wiśniewski, J. R., Zougman, A., Nagaraj, N., & Mann, M. (2009) · Nature Methods · doi:10.1038/nmeth.1322 · Cited by 8,352
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 2×
“, 2010), a characteristic feature in Alzheimer’s disease (Terry et al., 1991; Honer, 2003) and increasing attention is now being devoted to their role in synucleinopathies (Aarsland et al.”
BackgroundThe molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917
Cited by
Items 201–222 of 222
High-gamma frequency flash stimulation as a possible cognitive facilitator in rat pups
Fu, Y., & Zhai, Q. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149314
Overexpression of SFPQ Improves Cognition and Memory in AD Mice
Tie, J.-S., Wu, H., Liu, W., Li, Y., Li, L., Zhao, S., Yuan, Z., Mahmood, K., Chen, S., & Wu, H. (2025) · Neural Plasticity · doi:10.1155/np/3934591
“Patients with AD commonly exhibit decreased executive function and reasoning, which result from changes in the synaptic proteome [29, 30].”
Chan, D., Spires‐Jones, T. L., Provenzano, F. A., Glennon, E. B. C., & Duff, K. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780190065324.003.0020
Gudmundsen, F., Li, Z., Baun, C., Svensson, J. E., Langkjær, N., Palner, M., & Plavén‐Sigray, P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.11.642549
“More recently, PET imaging of synaptic vesicle glycoprotein 2A (SV2A) [12–14] has enabled in vivo quantification of synaptic density, providing new opportunities to track synapse loss [15,16], which is a key feature of neurodegeneration [17,18] that correlates strongly with cognitive decline [19].”
Bishara, M. A., Chum, P. P., Miot, F. E. L., Hooda, A., Hartman, R. E., & Behringer, E. J. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1667585 · Cited by 2
Frigerio, I., Bouwman, M. M. A., Noordermeer, R. T. G. M. M., Podobnik, E., Popovic, M., Timmermans, E., Rozemüller, A. J. M., van de Berg, W. D. J., & Jonkman, L. E. (2024) · Figshare · doi:10.6084/m9.figshare.24940514
Shi, H., Ge, X., Ma, X., Zheng, M., Cui, X., Pan, W., Zheng, P., Yang, X., Zhang, P., Hu, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16986964
Frigerio, I., Bouwman, M. M. A., Noordermeer, R. T. G. M. M., Podobnik, E., Popovic, M., Timmermans, E., Rozemüller, A. J. M., van de Berg, W. D. J., & Jonkman, L. E. (2024) · Figshare · doi:10.6084/m9.figshare.24940958
Frigerio, I., Bouwman, M. M. A., Noordermeer, R. T. G. M. M., Podobnik, E., Popovic, M., Timmermans, E., Rozemüller, A. J. M., van de Berg, W. D. J., & Jonkman, L. E. (2024) · Figshare · doi:10.6084/m9.figshare.26660236
Mravinacová, S., Alanko, V., Bergström, S., Bridel, C., Pijnenburg, Y. A. L., Hagman, G., Kivipelto, M., Teunissen, C. E., Nilsson, P., Matton, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26680313
Emekeeva, D. D., Chen, J., Yang, Y., Yang, J.-H., Gorshkov, M. V., & Tarasova, I. A. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251414414
“22 The dataset #2 collected from glioma samples was used to evaluate AD-speci fi c markers compared with different brain pathologies and age.”
Développement et caractérisation de nouveaux modèles murins de maladie à corps de Lewy
Schueller, E. (2020) · theses.fr (ABES) · doi:10.70675/4a313736z3f42z4d92zb1c1ze3cbd7bbe9f6 · Cited by 1
Liouta, K. (2022) · theses.fr (ABES) · doi:10.70675/f9158590zaaedz4b4bzacf2z430a26388e5f · Cited by 1
Dautricourt, S. (2021) · theses.fr (ABES) · doi:10.70675/63472a25z31eaz4ebczaebdzd8d2e061b4b8
The Use of Localized Proteomics to Understand the Pathogenesis of Alzheimer's Disease
Pires, G. (2021) · theses.fr (ABES) · doi:10.70675/45826fd6zd2c8z4b3dz91e0za5080544cb17
The role of the α7 nicotinic acetylcholine receptor in a model of amyloid pathology
Santos, D. G. (2024) · theses.fr (ABES) · doi:10.70675/b3ed4de5zcd9ez4421za129z0a05130d86b9
Effectiveness of computerized cognitive stimulation in Chilean older adults
Caldichoury, N., Sánchez, H., Coronado, J.-C., Ripoll-Córdoba, D., Morales-Asencio, B., Porto, M. F., Romo, C., Flórez, Y., Saldaña, C., Quispe-Ayala, C., et al. (2026) · Psychiatria Danubina · doi:10.24869/psyd.2026.45
“…hand, there are alterations in the anatomy, biology, and biochemistry of the nervous system that are not part of healthy aging and are associated with neuro-degenerative disorders (Kumar et al., 2018), leading to progressive cognitive decline (Bereczki et al., 2018; Gó-mez-Gómez & Zapico, 2019).”
Synaptic health in brain disorders: Impact of nanoplastic exposure
Ijomone, O. K., Omotosho, O. I., Awoyemi, I. L., Ovwere, I. R., Okeowo, O. M., Oyeniran, D. A., Oyerinde, T. O., Anadu, V. E., Gbayisomore, T. J., & Ijomone, O. M. (2026) · Advances in neurotoxicology · doi:10.1016/bs.ant.2026.03.011
Extracellular Vesicles in Personalized Medicine: Precision Diagnostics, Tailored Therapies
Mohammadzadeh, S., Heidari, A., Dehghani, P., Mirzamohammadi, M., Hatkehlouei, S. A. T., Emami, M. H., & Maghool, F. (2026) · Molecular and translational medicine · doi:10.1007/978-3-032-23810-8_12
Altered synaptic and astrocytic proteins in Lewy body disorders associated with GBA mutations
Eid, T. M., Lashley, T., Warner, T. T., Khan, A., Jantrachotechatchawan, C., Francis, P. T., Hardy, J., & Bandopadhyay, R. (2026) · Brain Communications · doi:10.1093/braincomms/fcag246
“9,21 We also investigated additional set of pre-synaptic (Rab3A and VAMP2) markers that were found to be altered in the literature, and one astrocytic (VAMP3) protein to investigate the involvement of inflammatory pathway.”
Self-citationSreeram, S., 陈雅, Bury, L. A. D., Leskov, K., Ye, F., García‐Mesa, Y., Luttge, B. G., Eum, J., 黄军友, Kallianpur, A. R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.10.743763
Brains for dementia research at 18: Commitment to impact the value of human post‐mortem tissue
Brookes, K. J., Barnett, N. A., Jackson, J., Kidd, E. J., Lett, D. J., Madine, J., Middlehurst, B., Palmer, L. E., Parkkinen, L., Robinson, A., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71956
“71,72 Increased microglia activation associated with dementia pheno-typeshasbeenobservedinseveralmodelorganismsforexmaple 73 and importantly confirmed in human post-mortem tissue.”
Metadata
- Authors
- Bereczki, E., Branca, R. M., Francis, P. T., Pereira, J. B., Baek, J.-H., Hortobágyi, T., Winblad, B., Ballard, C., Lehtiö, J., & Aarsland, D.
- Affiliations
- Karolinska Institutet (SE)
- Science for Life Laboratory (SE)
- King's College London (GB)
- University of Debrecen (HU)
- Corresponding author
- Bereczki, Erika
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-01-09
- Volume
- 141
- Issue
- 2
- Pages
- 582-595
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC5837272
- OpenAlex
- W2782564735
- Cited by
- 220
- References
- 71
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 31 · 2023: 25 · 2022: 29 · 2021: 32 · 2020: 36 · 2019: 21 · 2018: 17
- FWCI
- 17.06
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Funders
- Alzheimerfonden
- Parkinsonfonden
- Stohnes Stiftelse
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- synaptic proteins, cognitive decline, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease dementia, dementia with Lewy bodies, prefrontal cortex, SV2C, GRIA3, synaptotagmin 2, protein biomarkers, differential diagnosis
- MeSH terms
- Aged, Aged, 80 and over, Brain, Cognition Disorders, Female, Gene Expression Regulation, Humans, Male, Membrane Proteins, Microtubule-Associated Proteins, Nerve Tissue Proteins, Neurologic Examination, Neuropsychological Tests, Synapses, Neurodegenerative Diseases, Proteomics, Intracellular Signaling Peptides and Proteins, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.